Dr. Meves’ clinical interests are related to skin cancer, specifically melanoma. His research focuses on the biology of skin cancer, specifically as it relates to the remodeling of connective tissue and the extracellular matrix. He also aims to translate basic research into new and innovative methods to diagnose and treat skin cancer. For example, he co-developed the SkylineDx CP-GEP model for primary melanoma risk-stratification and works with colleagues at Mayo Clinic and Exact Sciences on ‘liquid biopsy’ diagnostic tests for metastatic melanoma.
Professor IJzerman is leading a global research program focused on the health economics and service delivery of precision medicine, in particular oncology. The research program includes the use of real-world (linked) data for health services research, the use of decision modelling methods for biomarker development, patient-preferences research and dynamic treatment sequencing.
Dr Mitchell Stark, University of Queensland
Dr Andrew Colebatch, University of New South Wales
Dr Oliver Klein, Olivia Newton-John Cancer Research Institute
Prof Tony Papenfuss, Walter & Eliza Hall Institute and Peter MacCallum Cancer Centre
Dr Louise Jackett, Austin Health
Dr Jess Duarte, Olivia Newton-John Cancer Research Institute
Dr Joseph Cursons, Walter & Eliza Hall Institute and oNKo-innate
A/Prof Victoria Mar, Victorian Melanoma Service, Alfred Health
A/Prof Alex Dobrovic, Olivia Newton-John Cancer Research Institute
Dr Amir Iravani, Peter MacCallum Cancer Centre
Dr Inês Silva, Melanoma Institute Australia
Convened by Dr David Gyorki, VCCC Research & Education Lead in Melanoma & Skin Cancers.
The symposium is presented by the Victorian Comprehensive Cancer Centre in collaboration with Melanoma Research Victoria
Can't attend in person? Register for Webinar
